Knights Of Columbus Asset Advisors LLC Intellia Therapeutics, Inc. Transaction History

Knights Of Columbus Asset Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$23.16 - $32.34 $8,800 - $12,289	380 Added 37.18%	1,402 $42,000
Q3 2023 Nov 01, 2023	BUY	$31.62 - $45.78 $2,782 - $4,028	88 Added 9.42%	1,022 $32,000
Q2 2023 Jul 31, 2023	SELL	$34.58 - $46.03 $201,912 - $268,769	-5,839 Reduced 86.21%	934 $38,000
Q1 2023 May 01, 2023	SELL	$33.3 - $44.82 $375,990 - $506,062	-11,291 Reduced 62.51%	6,773 $252,000
Q4 2022 Jan 31, 2023	SELL	$33.21 - $62.69 $9,763 - $18,430	-294 Reduced 1.6%	18,064 $630,000
Q3 2022 Nov 10, 2022	BUY	$53.92 - $71.7 $989,863 - $1.32 Million	18,358 New	18,358 $1.03 Million

314

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $926M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Knights Of Columbus Asset Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Knights Of Columbus Asset Advisors LLC with notifications on news.